← Back to Clinical Trials
Recruiting NCT07125001

Mango Intake and Gut and Cardiometabolic Health in Hispanic/Latino Adolescents

◆ AI Clinical Summary
Plain-language summary for patients

Trial Parameters

Condition Cardiometabolic Health Indicators
Sponsor University of California, Davis
Study Type INTERVENTIONAL
Phase N/A
Enrollment 25
Sex ALL
Min Age 12 Years
Max Age 19 Years
Start Date 2025-10-01
Completion 2028-03-31
Interventions
Ataulfo mango

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

Mangos contain a number of nutrients that may improve gut and metabolic health. The purpose of this research is to see how eating mangos every day for 4 weeks instead of snacks high in calories and low in nutrients such as cookies, crackers, chips, and candy can impact adolescent health.

Eligibility Criteria

Inclusion Criteria: * \- Male or Female 12-19 years old * BMI ≥ 85th percentile (https://www.bcm.edu/bodycomplab/BMIapp/BMI-calculator-kids.html) * Self-reported Hispanic/Latino * Subject is willing and able to comply with the study protocols * Subject is willing to consume the test products * Female-specific criteria: if menstruating, eumenorrheic (regular monthly menstrual cycles of 25-30-days in length) * Access to a smartphone or tablet at least 1x / day and willing to take pictures associated with the products to be consumed in the study Exclusion Criteria: * \- Reported food allergies. * Currently taking prescription drugs, with the exception of asthma inhalers, which are allowed * BMI \<85th percentile (https://www.bcm.edu/bodycomplab/BMIapp/BMI-calculator-kids.html) * Current participation in a moderate or high-intensity daily exercise routine * Self-reported disease, serious illness, or who are currently under acute medical care. * Currently taking prescription drugs. * Any su

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology
}